Fmr LLC sold $992k of BEAM
owner, other at Beam Therapeutics Inc.. 48,374 shares at an average of $20.50, traded Jul 30, 2025, filed Aug 1, 2025.
Score components
- +12Role10% owner
- +25Trade size$992k at market
- 0Share of holdings soldSold 2.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-101143, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | SOpen-market sale Common Stockindirect: Shares held by persons and entities whose shares are subject to reporting by the undersigned. | -48,374 | $20.50 | $992k | 2,073,665 | Aug 1, 2025 |
Related signals
Other insiders at Beam Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 2Weak | Beam Therapeutics Inc. | Bethany J Cavanagh SVP, Finance and Treasurer | $4,565 187 shares | -0% | |
| 0Weak | Beam Therapeutics Inc. | Amy Simon Chief Medical Officer | $24k 1,250 shares | -2% | |
| 39Weak | Beam Therapeutics Inc. | Amy Simon Chief Medical Officer | $548k 30,563 shares | -32% | |
| 24Weak | Beam Therapeutics Inc. | Bethany J Cavanagh SVP, Finance and Treasurer | $55k 3,015 shares | -6% | |
| 26Weak | Beam Therapeutics Inc. | Giuseppe Ciaramella President | $136k 7,434 shares | -4% | |
| 39Weak | Beam Therapeutics Inc. | John M. Evans CEO | $563k 30,663 shares | -3% | |
| 20Weak | Beam Therapeutics Inc. | Christine Bellon Chief Legal Officer | $104k 5,674 shares | -5% | |
| 27Weak | Beam Therapeutics Inc. | Bethany J Cavanagh SVP, Finance and Treasurer | $220k 6,287 shares | -14% | |
| 3Weak | Beam Therapeutics Inc. | Christine Bellon Chief Legal Officer | $340k 10,000 shares | -9% | |
| 27Weak | Beam Therapeutics Inc. | John M. Evans CEO | $802k 30,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.